Global Travel Vaccines Market to Grow at 9.6% During 2024-2032, Propelled by Increasing International Tourism

January 04, 2022 | Healthcare

The latest report by IMARC Group titled, “Travel Vaccines Market Report by Composition (Mono Vaccines, Combination Vaccines), Disease (Hepatitis A, DPT, Yellow Fever, Typhoid, Hepatitis B, Measles and Mumps, Rabies, Meningococcal, Varicella, Japanese Encephalitis, and Others), and Region 2024-2032” finds that the global travel vaccines market reached a value of US$ 4.0 Billion in 2023. Travel vaccines, also known as travel immunizations, are shots that travelers receive before visiting certain parts of the world where there is a high risk of developing certain diseases. These vaccines introduce the disease-causing microbes into the bloodstream to help the human body produce antibodies that will fight off the same if the person is exposed to the disease again. These shots must be taken at least 4 to 6 weeks before traveling, as it gives enough time for the immunization to start working efficiently.

Global Travel Vaccines Market Trends:

The market is primarily driven by the rising occurrence of infectious and travel-related diseases such as diphtheria, Japanese encephalitis, meningitis, and yellow fever. In addition, there has been significant growth in international tourism due to rapid globalization and reduced international airfares. As a result, the demand for travel vaccines has witnessed substantial growth across the globe. Besides this, combination vaccines are gaining popularity among travelers as they protect against multiple diseases and reduce the number of vaccines required, thereby contributing to the market growth. Moreover, travel vaccines have become an essential requirement in an international travelers list as governments of numerous countries have mandated that travelers should be vaccinated before visiting disease-prone regions. For instance, the National Health Service (NHS) is providing several free travel vaccines for diseases, such as cholera, polio, typhoid and hepatitis A, in the United Kingdom to reduce the risk of these diseases being spread across the country. On account of these factors, IMARC Group expects the market to grow at a CAGR of 9.6% during 2024-2032.

Market Summary:

  • On the basis of the composition, the market has been bifurcated into mono and combination vaccines. At present, combination vaccines account for the majority of the market share.
  • Based on the disease, the market has been segmented into hepatitis A, DPT, yellow fever, typhoid, hepatitis B, measles and mumps, rabies, meningococcal, varicella, Japanese encephalitis, and others. Amongst these, hepatitis A exhibits a clear dominance in the market.
  • On the geographical front, North America holds the leading position in the market. Other major regions include Europe, Asia Pacific, Middle East and Africa, and Latin America.
  • The competitive landscape of the market has also been analyzed in the report, with some of the major players being GlaxoSmithKline Pharmaceuticals Limited, Sanofi Pasteur, Merck & Co., Inc., Novartis AG, Pfizer Inc., ALK -Abelló A/S, Bavarian Nordic A/S, Crucell (Subsidiary of Johnson & Johnson), CSL Limited, AstraZeneca PLC, Altimmune, Inc., Abbott Laboratories, Hoffmann-La Roche, Inc.

Report Coverage:

Report Features Details
Base Year of the Analysis 2023
Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Billion
Segment Coverage Composition, Disease, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Companies Covered GlaxoSmithKline Pharmaceuticals Limited, Sanofi Pasteur, Merck & Co., Inc., Novartis AG, Pfizer Inc., ALK-Abelló A/S, Bavarian Nordic A/S, Crucell (Subsidiary of Johnson & Johnson), CSL Limited, AstraZeneca PLC, Altimmune, Inc., Abbott Laboratories and Hoffmann-La Roche, Inc.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

30 N Gould St Ste R
Sheridan, WY 82801 USA - Wyoming
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global Travel Vaccines Market to Grow at 9.6% During 2024-2032, Propelled by Increasing International Tourism
Purchase options

Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us

Phone: +1-631-791-1145


Phone: +91-120-433-0800


Phone: +44-753-714-6104


Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More